Cardiomyocyte proliferation in mice expressing α-cardiac myosin heavy chain-SV40 T-antigen transgenes

E. B. Katz, M. E. Steinhelper, J. B. Delcarpio, A. I. Daud, W. C. Claycomb, Loren Field

Research output: Contribution to journalArticle

98 Citations (Scopus)

Abstract

To determine the proliferative potential of adult ventricular cardiomyocytes, we have generated transgenic mice that express the SV40 large T-antigen oncogene in the heart. A fusion gene comprised of the rat α- cardiac myosin heavy chain promoter and the SV40 early region was used to target oncogene expression to the myocardium. Expression of SV40 large T- antigen was observed in both atrial and ventricular cardiomyocytes in adult transgenic animals. T-antigen expression was associated with hyperplasia in the targeted cells. Immunohistological analysis indicated that the proliferating cells continued to express sarcomeric myosin. Electron microscopic examination demonstrated that cardiomyocytes in various stages of the cell cycle retained ultrastructural characteristics typical of mitotic cardiac muscle cells in vivo. Cardiomyocytes isolated from transgenic tumors were able to proliferate in culture and retained a differentiated phenotype, as evidenced by spontaneous contractile activity. Preliminary studies indicate that these cells can undergo a limited number of passages while retaining this differentiated phenotype. These studies demonstrate that both ventricular and atrial cardiomyocytes from transgenic mice proliferate in response to targeted T-antigen expression.

Original languageEnglish
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume262
Issue number6 31-6
StatePublished - 1992

Fingerprint

Cardiac Myosins
Polyomavirus Transforming Antigens
Myosin Heavy Chains
Transgenes
Cardiac Myocytes
Viral Tumor Antigens
Oncogenes
Transgenic Mice
Phenotype
Genetically Modified Animals
Gene Fusion
Myosins
Hyperplasia
Myocardium
Cell Cycle
Electrons
Neoplasms

Keywords

  • cardiac tumorigenesis
  • cardiomyocyte growth
  • transgenic mice

ASJC Scopus subject areas

  • Physiology

Cite this

Cardiomyocyte proliferation in mice expressing α-cardiac myosin heavy chain-SV40 T-antigen transgenes. / Katz, E. B.; Steinhelper, M. E.; Delcarpio, J. B.; Daud, A. I.; Claycomb, W. C.; Field, Loren.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 262, No. 6 31-6, 1992.

Research output: Contribution to journalArticle

Katz, E. B. ; Steinhelper, M. E. ; Delcarpio, J. B. ; Daud, A. I. ; Claycomb, W. C. ; Field, Loren. / Cardiomyocyte proliferation in mice expressing α-cardiac myosin heavy chain-SV40 T-antigen transgenes. In: American Journal of Physiology - Heart and Circulatory Physiology. 1992 ; Vol. 262, No. 6 31-6.
@article{e37d91031f704d0fa5151cb50b5cbf1f,
title = "Cardiomyocyte proliferation in mice expressing α-cardiac myosin heavy chain-SV40 T-antigen transgenes",
abstract = "To determine the proliferative potential of adult ventricular cardiomyocytes, we have generated transgenic mice that express the SV40 large T-antigen oncogene in the heart. A fusion gene comprised of the rat α- cardiac myosin heavy chain promoter and the SV40 early region was used to target oncogene expression to the myocardium. Expression of SV40 large T- antigen was observed in both atrial and ventricular cardiomyocytes in adult transgenic animals. T-antigen expression was associated with hyperplasia in the targeted cells. Immunohistological analysis indicated that the proliferating cells continued to express sarcomeric myosin. Electron microscopic examination demonstrated that cardiomyocytes in various stages of the cell cycle retained ultrastructural characteristics typical of mitotic cardiac muscle cells in vivo. Cardiomyocytes isolated from transgenic tumors were able to proliferate in culture and retained a differentiated phenotype, as evidenced by spontaneous contractile activity. Preliminary studies indicate that these cells can undergo a limited number of passages while retaining this differentiated phenotype. These studies demonstrate that both ventricular and atrial cardiomyocytes from transgenic mice proliferate in response to targeted T-antigen expression.",
keywords = "cardiac tumorigenesis, cardiomyocyte growth, transgenic mice",
author = "Katz, {E. B.} and Steinhelper, {M. E.} and Delcarpio, {J. B.} and Daud, {A. I.} and Claycomb, {W. C.} and Loren Field",
year = "1992",
language = "English",
volume = "262",
journal = "American Journal of Physiology",
issn = "0193-1857",
publisher = "American Physiological Society",
number = "6 31-6",

}

TY - JOUR

T1 - Cardiomyocyte proliferation in mice expressing α-cardiac myosin heavy chain-SV40 T-antigen transgenes

AU - Katz, E. B.

AU - Steinhelper, M. E.

AU - Delcarpio, J. B.

AU - Daud, A. I.

AU - Claycomb, W. C.

AU - Field, Loren

PY - 1992

Y1 - 1992

N2 - To determine the proliferative potential of adult ventricular cardiomyocytes, we have generated transgenic mice that express the SV40 large T-antigen oncogene in the heart. A fusion gene comprised of the rat α- cardiac myosin heavy chain promoter and the SV40 early region was used to target oncogene expression to the myocardium. Expression of SV40 large T- antigen was observed in both atrial and ventricular cardiomyocytes in adult transgenic animals. T-antigen expression was associated with hyperplasia in the targeted cells. Immunohistological analysis indicated that the proliferating cells continued to express sarcomeric myosin. Electron microscopic examination demonstrated that cardiomyocytes in various stages of the cell cycle retained ultrastructural characteristics typical of mitotic cardiac muscle cells in vivo. Cardiomyocytes isolated from transgenic tumors were able to proliferate in culture and retained a differentiated phenotype, as evidenced by spontaneous contractile activity. Preliminary studies indicate that these cells can undergo a limited number of passages while retaining this differentiated phenotype. These studies demonstrate that both ventricular and atrial cardiomyocytes from transgenic mice proliferate in response to targeted T-antigen expression.

AB - To determine the proliferative potential of adult ventricular cardiomyocytes, we have generated transgenic mice that express the SV40 large T-antigen oncogene in the heart. A fusion gene comprised of the rat α- cardiac myosin heavy chain promoter and the SV40 early region was used to target oncogene expression to the myocardium. Expression of SV40 large T- antigen was observed in both atrial and ventricular cardiomyocytes in adult transgenic animals. T-antigen expression was associated with hyperplasia in the targeted cells. Immunohistological analysis indicated that the proliferating cells continued to express sarcomeric myosin. Electron microscopic examination demonstrated that cardiomyocytes in various stages of the cell cycle retained ultrastructural characteristics typical of mitotic cardiac muscle cells in vivo. Cardiomyocytes isolated from transgenic tumors were able to proliferate in culture and retained a differentiated phenotype, as evidenced by spontaneous contractile activity. Preliminary studies indicate that these cells can undergo a limited number of passages while retaining this differentiated phenotype. These studies demonstrate that both ventricular and atrial cardiomyocytes from transgenic mice proliferate in response to targeted T-antigen expression.

KW - cardiac tumorigenesis

KW - cardiomyocyte growth

KW - transgenic mice

UR - http://www.scopus.com/inward/record.url?scp=0026625518&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026625518&partnerID=8YFLogxK

M3 - Article

C2 - 1377879

AN - SCOPUS:0026625518

VL - 262

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 0193-1857

IS - 6 31-6

ER -